InvestorsHub Logo
Followers 3
Posts 148
Boards Moderated 0
Alias Born 08/21/2020

Re: None

Wednesday, 09/30/2020 9:15:49 AM

Wednesday, September 30, 2020 9:15:49 AM

Post# of 1192
$HUGE : NASDAQ

FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients

Published: Sep 28, 2020

FDA has authorized randomized, controlled, double-blind, multicenter study on 352 patients

https://www.biospace.com/article/releases/fsd-pharma-begins-phase-2-clinical-trial-to-evaluate-fsd201-for-the-treatment-of-hospitalized-covid-19-patients